"1210-7859" . "C\u00EDlem p\u0159edlo\u017Een\u00E9 pr\u00E1ce bylo z\u00EDskat p\u0159ehled o situaci v \u010CR u populace nadu\u017E\u00EDvaj\u00EDc\u00ED medikaci k ovlivn\u011Bn\u00ED bolest\u00ED hlavy (analgetika jednoslo\u017Ekov\u00E1, kombinovan\u00E1, nesteroidn\u00ED antirevmatika, dihydroergotamin, triptany, opioidy). Do souboru byli za\u0159azeni pacienti, kte\u0159\u00ED se dostavili poprv\u00E9 do specializovan\u00FDch center pro diagnostiku a l\u00E9\u010Dbu bolest\u00ED hlavy v intervalu od 1. 1. 2008 do 30. 6. 2008 a kte\u0159\u00ED spl\u0148ovali krit\u00E9ria nadu\u017E\u00EDv\u00E1n\u00ED t\u00E9to medikace dle IHS. Byly zji\u0161\u0165ov\u00E1ny demografick\u00E9 \u00FAdaje sledovan\u00FDch pacient\u016F, stanoven typ bolesti hlavy, byla zaznamen\u00E1v\u00E1na d\u00E9lka obt\u00ED\u017E\u00ED, jejich pr\u016Fm\u011Brn\u00E1 intenzita i frekvence. Celkem byly hodnoceny \u00FAdaje 153 pacient\u016F ze sedmi center, z nich\u017E bylo 114 \u017Een a 39 mu\u017E\u016F. Pr\u016Fm\u011Brn\u00FD v\u011Bk t\u011Bchto pacient\u016F byl 46 rok\u016F, dobu trv\u00E1n\u00ED bolest\u00ED hlavy ud\u00E1vali v pr\u016Fm\u011Bru 21 rok\u016F a frekvenci obt\u00ED\u017E\u00ED 21 dn\u016F v m\u011Bs\u00EDci. Z celkov\u00E9ho po\u010Dtu nadu\u017E\u00EDvalo 62 % pacient\u016F jeden prepar\u00E1t, 30 % dva l\u00E9ky a 8 % l\u00E9ky t\u0159i. Nej\u010Dast\u011Bji nadu\u017E\u00EDvan\u00FDm l\u00E9kem byl sumatriptan ve 30 %, na druh\u00E9m m\u00EDst\u011B ibuprofen ve 23 %, po n\u011Bm n\u00E1sledoval eletriptan ve 20 %. V pr\u016Fm\u011Bru u\u017E\u00EDvali pacienti 35 tablet za m\u011Bs\u00EDc po pr\u016Fm\u011Brnou dobu \u010Dty\u0159 let." . "Medication Overuse in Chronic Daily Headache Patients in the Czech Republic"@en . "8"^^ . "I, N, V" . "Nadu\u017E\u00EDv\u00E1n\u00ED l\u00E9k\u016F pacienty s chronickou denn\u00ED bolest\u00ED hlavy v \u010Cesk\u00E9 republice" . "Dole\u017Eil, David" . "Medication Overuse in Chronic Daily Headache Patients in the Czech Republic"@en . . "1" . "analgesics; triptans; medication overuse; chronic migraine; chronic daily deadache"@en . . "L\u00E1nsk\u00E1, V." . "Do\u010Dekal, Petr" . "Nadu\u017E\u00EDv\u00E1n\u00ED l\u00E9k\u016F pacienty s chronickou denn\u00ED bolest\u00ED hlavy v \u010Cesk\u00E9 republice"@cs . "Nadu\u017E\u00EDv\u00E1n\u00ED l\u00E9k\u016F pacienty s chronickou denn\u00ED bolest\u00ED hlavy v \u010Cesk\u00E9 republice"@cs . . "The aim of our study was to evaluate the situation in the Czech Republic among that segment of the population that uses headache medication (analgesics combined or with single compound, non-steroidal anti-inflammatory drugs [NSAIDs], dihydroergotamine, triptans, and opioids) to excess. We included patients presenting the first time between 1st January and 30th June 2008 at specialised centres for the diagnosis and treatment of headache. All the patients fulfilled criteria for medication overuse according to the International Headache Society. We acquired demographic data, assessed the headache type, and established how long the subjects had suffered, as well as the average intensity and frequency of occurrence. We assessed data from 153 patients from seven sites, 39 men and 114 women. Average age was 46 years, patients had suffered for an headaches for an average of 21 years and the average frequency was 21 days per month. One compound was overused by 62% patients; 30% of the patients overused two substances and 8% three of them. The most commonly overused medication was sumatriptan at 30%, second was ibuprofen at 23%, followed by eletriptan at 20%. Patients were using an average of 35 pills per month for an average span of four years."@en . "Markov\u00E1, J." . "214648" . . "Nadu\u017E\u00EDv\u00E1n\u00ED l\u00E9k\u016F pacienty s chronickou denn\u00ED bolest\u00ED hlavy v \u010Cesk\u00E9 republice" . "000287787700010" . "CZ - \u010Cesk\u00E1 republika" . "Kotas, Rudolf" . "[25EAED18B537]" . . "RIV/00216208:11140/11:10133220" . . "\u010Cesk\u00E1 a slovensk\u00E1 neurologie a neurochirurgie" . "Niedermayerov\u00E1, I." . . . . . "11140" . . "5"^^ . . . . . "1"^^ . . . "C\u00EDlem p\u0159edlo\u017Een\u00E9 pr\u00E1ce bylo z\u00EDskat p\u0159ehled o situaci v \u010CR u populace nadu\u017E\u00EDvaj\u00EDc\u00ED medikaci k ovlivn\u011Bn\u00ED bolest\u00ED hlavy (analgetika jednoslo\u017Ekov\u00E1, kombinovan\u00E1, nesteroidn\u00ED antirevmatika, dihydroergotamin, triptany, opioidy). Do souboru byli za\u0159azeni pacienti, kte\u0159\u00ED se dostavili poprv\u00E9 do specializovan\u00FDch center pro diagnostiku a l\u00E9\u010Dbu bolest\u00ED hlavy v intervalu od 1. 1. 2008 do 30. 6. 2008 a kte\u0159\u00ED spl\u0148ovali krit\u00E9ria nadu\u017E\u00EDv\u00E1n\u00ED t\u00E9to medikace dle IHS. Byly zji\u0161\u0165ov\u00E1ny demografick\u00E9 \u00FAdaje sledovan\u00FDch pacient\u016F, stanoven typ bolesti hlavy, byla zaznamen\u00E1v\u00E1na d\u00E9lka obt\u00ED\u017E\u00ED, jejich pr\u016Fm\u011Brn\u00E1 intenzita i frekvence. Celkem byly hodnoceny \u00FAdaje 153 pacient\u016F ze sedmi center, z nich\u017E bylo 114 \u017Een a 39 mu\u017E\u016F. Pr\u016Fm\u011Brn\u00FD v\u011Bk t\u011Bchto pacient\u016F byl 46 rok\u016F, dobu trv\u00E1n\u00ED bolest\u00ED hlavy ud\u00E1vali v pr\u016Fm\u011Bru 21 rok\u016F a frekvenci obt\u00ED\u017E\u00ED 21 dn\u016F v m\u011Bs\u00EDci. Z celkov\u00E9ho po\u010Dtu nadu\u017E\u00EDvalo 62 % pacient\u016F jeden prepar\u00E1t, 30 % dva l\u00E9ky a 8 % l\u00E9ky t\u0159i. Nej\u010Dast\u011Bji nadu\u017E\u00EDvan\u00FDm l\u00E9kem byl sumatriptan ve 30 %, na druh\u00E9m m\u00EDst\u011B ibuprofen ve 23 %, po n\u011Bm n\u00E1sledoval eletriptan ve 20 %. V pr\u016Fm\u011Bru u\u017E\u00EDvali pacienti 35 tablet za m\u011Bs\u00EDc po pr\u016Fm\u011Brnou dobu \u010Dty\u0159 let."@cs . "74" . . "Rejda, J." . "Mast\u00EDk, J." . "RIV/00216208:11140/11:10133220!RIV13-MSM-11140___" . .